Article Text
Commentary
HBsAg seroclearance with NUCs: rare but important
Statistics from Altmetric.com
Footnotes
-
Contributors MC and CHzS wrote the commentary.
-
Competing interests MC has received lecture and consultant fees from Roche Pharma, Roche Diagnostics, Gilead, Merck, Bristol-Myers Squibb, and Novartis. MC has received grant support from Roche Pharma, Roche Diagnostics, and Merck.
-
Provenance and peer review Commissioned; internally peer reviewed.